America’s Health Insurance Plans (AHIP) said Wednesday that its board of directors has chosen Matt Eyles, its current senior executive vice president and chief operating officer, to succeed Marilyn Tavenner, as its new president and chief executive officer.
America’s Health Insurance Plans (AHIP) said Wednesday that its board of directors has chosen Matt Eyles, its current senior executive vice president and chief operating officer, to succeed Marilyn Tavenner as its new president and chief executive officer.
The move is effective June 1. AHIP said Eyles has worked closely with Tavenner—who is retiring—the Board, and AHIP members on a variety of issues and initiatives.
“It is an honor to represent insurance providers and the members they serve,” Eyles said in a statement. “We will continue to focus on solutions that deliver more affordable choices and higher quality for every American. It’s also an honor to have worked with and learned from Marilyn. For more than 40 years, she has driven important changes that have directly improved the lives of patients, consumers, and hardworking taxpayers.”
Eyles has led the policy and regulatory affairs function, including the Medicare and Medicaid, state policy, and product policy departments.
Eyles joined AHIP from Avalere Health. Before Avalere, he worked in public policy divisions of what would later become parts of different pharmaceutical companies. He began his career at the Congressional Budget Office.
Tavenner joined AHIP in 2015 from CMS. In a statement, she praised her successor's leadership. “We have partnered together on real solutions that allow health insurance providers to better serve the millions of Americans they work for every day," she said. "We worked closely with the Board to plan an effective transition to ensure that under Matt’s leadership, AHIP will continue to be the industry leader for years to come.”
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More